• Nenhum resultado encontrado

HEAD AND NECK CANCER: CONTRIBUTION FOR THE ANALYSIS OF THE REHABILITATION NEEDS

N/A
N/A
Protected

Academic year: 2019

Share "HEAD AND NECK CANCER: CONTRIBUTION FOR THE ANALYSIS OF THE REHABILITATION NEEDS"

Copied!
14
0
0

Texto

Loading

Imagem

GRAPHIC 1 -  Absolute frequency of surgical techniques.
TABLE 5 -  Absolute and relative frequencies of surgeries performed in “undefined locations of the oral cavity and  maxilla/mandible”.
TABLE 8 -  Distribution of absolute and relative frequencies of surgeries performed in the “pharyngolaryngeal region”.
TABLE 9 -  Absolute frequency of surgeries performed in accordance with topographical region and surgical option.
+3

Referências

Documentos relacionados

Neste trabalho o objetivo central foi a ampliação e adequação do procedimento e programa computacional baseado no programa comercial MSC.PATRAN, para a geração automática de modelos

Ousasse apontar algumas hipóteses para a solução desse problema público a partir do exposto dos autores usados como base para fundamentação teórica, da análise dos dados

tween MTR A2756G polymorphism and the risk for head and neck cancer and a higher frequency of carriers of the G allele variant in men with head and neck cancer

In the present study, the allele and genotype distribu- tion of the -1154G/A VEGF polymorphism in patients with head and neck cancer was in close agreement with that reported

As críticas mais frequentes a ele são: trata-se de mais um dos projetos faraônicos gestados pelo regime militar durante o milagre econômico; consumiu volumosos recursos por ordem

decrease as compared to Ti, reaching an ~80% reduction when a longer spacer was used (Ch_AHA_Nt-Dhvar5 and Ch_GG_Nt- Dhvar5) (p < 0.05). These two Dhvar-bearing surfaces did

The probability of attending school four our group of interest in this region increased by 6.5 percentage points after the expansion of the Bolsa Família program in 2007 and

In a previous study of head and neck cancer cases, the positive rate of HPV was 10% in patients with oral cavity cancer, 83.2% in those with oropharyngeal cancer, and 44.4% in those